Category
Baricitinib
CAS Number
1803583-30-3
Molecular Formula
C₉H₈ClN₅
Molecular Weight
221.65 g/mol
Synonym

4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine hydrochloride ; Baricitinib Diamine Hydrochloride Impurity;4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine;4-(1H-pyrazol-4-yl)-7H-pyrrolopyrimidine hydrochloride

Keywords
Janus kinase (JAK) inhibitors
Intermediates
Impurities
Impurities manufacturer and Suppliers in Hyderabad india
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Baricitinib Diamine Hydrochloride Impurity is a process-related impurity formed during the synthesis of Baricitinib, typically involving intermediate diamine compounds that react with hydrochloric acid. It is monitored and controlled under pharmaceutical quality standards to ensure it stays within acceptable limits, preserving the drug’s purity, safety, and effectiveness.